The Mexico Border Health Commission Models of Excellence initiative identifies and recognizes community health programs that improve access, prevention, and continuity of care along the 2,000-mile U.S. border in California, Arizona, New Mexico, and Texas. Programs are selected on documented outcomes, feasibility within existing staff and budgets, and suitability for replication. Review centers on a defined set of outcome measures that reflect timely care, preventive reach, chronic disease management, and overall continuity. Approved programs are then recorded in a common format, making it possible for other counties to adopt and apply them in practice.
Core Functions
Program identification. The initiative conducts structured reviews of county and clinic projects, drawing from local submissions and ongoing workstreams. Candidates are considered only if they operate within existing staff and budget limits and show potential for continuity. Selection follows evaluation principles used in public health planning frameworks such as the World Health Organization’s health systems strengthening guidance, which emphasize sustainability and equity of access.
Technical review. Each program undergoes an examination of its outcomes, workflows, and data quality. Independent contacts verify that results stem from the program itself rather than temporary grants or atypical staffing. The ability to be replicated is a key condition, so that counties with limited resources can still adopt the model and achieve consistent results.
Implementation support. Teams selected for recognition are given access to practical resources that help them bring a model into daily use. These resources include targeted training modules, startup guides, and reporting templates designed to keep data consistent from the first day of implementation. The goal is to make adoption straightforward while maintaining comparability across sites. This reflects established practice in cross-border health, where the Pan American Health Organization places priority on training and local capacity as the basis for lasting programs
Knowledge transfer. Every program that passes review is written up in a standard package covering staffing roles, timelines, and estimated costs. These materials are refined after the first replication cycle and then circulated so county leaders can apply them directly. The method reflects principles of evidence dissemination developed by the National Institutes of Health, where clarity and standardized reporting are central to effective scale-up. By anchoring documentation in this way, the initiative ensures that each program is not only recognized but also usable and measurable in different community settings.
Partnerships and coordination. Collaboration is a core element of the initiative. Local clinics, public health agencies, and universities work under joint agreements that define responsibilities and reporting lines. In several projects, the Mexican Pharma also participates, helping with medication logistics, patient navigation, and continuity after discharge under agreed protocols. This type of partnership shows how cross-border actors can be integrated into routine systems of care.
Ongoing verification. Program performance is reviewed every quarter. Results are compared with baseline measures, and any departure from the documented workflow is noted early. This allows corrections to be made before projects are scaled further and helps ensure that new sites apply models in line with established practice.
Case Profiles
Programs selected under the initiative illustrate how targeted interventions can change outcomes in complex border settings.
Tuberculosis management is one of the most consistent examples: county clinics working under binational referral protocols have shortened the time from diagnosis to treatment start and increased therapy completion rates, reducing the number of patients lost to follow up. These workflows are structured around CDC contact-investigation standards and adapted for mobile populations that frequently cross jurisdictions.
Maternal and child health initiatives demonstrate a different layer of impact. Mobile prenatal routes aligned with school calendars and WIC programs have improved early enrollment and continuity after delivery. Reports from participating counties note higher vaccination coverage for infants and fewer missed postpartum visits in rural towns.
Chronic disease prevention has been advanced through nutrition programs that provide fresh produce while also carrying out screening for high blood pressure and diabetes. By combining access to food with early checks, these programs follow the priorities of Healthy Border 2030 and have already been linked with fewer complications reported in local clinics.
Continuity of care is also reinforced through networks such as MCN’s Health Network. These systems track treatment for mobile and migrant populations, making sure that care continues when patients move for employment or family reasons.
Standards and Criteria
Programs are expected to function under routine staffing and budget conditions, show clear evidence of benefit, and be capable of replication beyond their original site. Selection looks at whether the model is sustainable, responds to actual community needs, and can produce results that hold up over time.
To guide this process, the initiative references established evaluation tools such as the PRECEDE–PROCEED model, which is widely used in public health planning. Planning is built around the expected outcomes first, with each practical step mapped in reverse to make sure the path is clear. This way, interventions are tied to real goals and remain both measurable and adaptable for use in different communities.
The standards make it possible to identify programs that show local success and to present them in a format suited for replication and sustained impact.
Observed Results
The initiative has shown consistent progress in strengthening health capacity along the border. Local systems report shorter delays in starting treatment, more reliable follow up, and stronger continuity of care. Preventive measures have expanded, and access to basic services has become steadier in areas where resources were previously limited. Programs recognized under the initiative demonstrate that results can be measured, transferred, and sustained when workflows are documented and supported. Over time, this approach has created a foundation where tested models no longer remain isolated projects but function as practical tools that counties and partners can adopt to improve overall health outcomes.
About United States-Mexico Border Health Commission
The United States-Mexico Border Health Commission is a binational body created to address persistent public health challenges along the border region. Headquartered in El Paso, Texas, the Commission provides a formal mechanism for collaboration between federal, state, and local institutions in both countries. Its mandate is to improve health outcomes in underserved border communities through joint programs, technical cooperation, and data-driven strategies. Core activities include surveillance, policy development, prevention initiatives, and capacity building.
Contacts
United States-Mexico Border Health Commission, info@borderhealth.org
211 N. Florence, Suite 101- El Paso, TX 79901, 915-532-1006 or 1-866-785-9867